A comprehensive view of Injectables/Infusions/IV Drips. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

American Regent launches FDA-approved injectable Atropine Sulfate; drug serves as temporary blockade of severe, life-threatening muscarinic effects, as an organophosphorus, muscarinic mushroom poisoning antidote, and to treat bradyasystolic cardiac arrest

Assure Infusions building 60,000 square-foot, fully automated IV fluid manufacturing plant in Bartow, Florida, to open in 2023; Assure launched in 2022 to make sterile IV fluids such as dextrose, Ringer’s lactate, normal saline, sterile water

FDA to conduct clinical trial of Siga Technologies’ Tpoxx tecovirimat oral and injectable antiviral as a treatment for monkeypox; CDC reports 7,510 monkeypox cases in US

FDA starts priority review of Eli Lilly’s donanemab injectable Alzheimer drug designed to clear amyloid plaque from brain; late-stage study results expected by middle of 2023

Regeneron ends four early-to-late stage clinical trials of injectable REGEN-COV because emerging SARS-CoV-2 variants are impacting studies; studies involved drug as treatment for hospitalized children, non-hospitalized patients

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count